PharmAsia News
August 16, 2013
Executive SummaryAdcock Ingram indicated it expects to reach an agreement with Chile's CFR Pharmaceuticals to take over the South Africa drug maker, with the financial talk now at $1.3 billion.
Adcock Ingram indicated it expects to reach an agreement with Chile's CFR Pharmaceuticals to take over the South Africa drug maker, with the financial talk now at $1.3 billion. The company said other suitors, which it did not identify, continue to make proposals, but none has offered a bid that matches CFR's, so its discussions continue only with the Chile company. Beyond that, Adcock offered no further details about the talks.
Executive SummaryAdcock Ingram indicated it expects to reach an agreement with Chile's CFR Pharmaceuticals to take over the South Africa drug maker, with the financial talk now at $1.3 billion.
Adcock Ingram indicated it expects to reach an agreement with Chile's CFR Pharmaceuticals to take over the South Africa drug maker, with the financial talk now at $1.3 billion. The company said other suitors, which it did not identify, continue to make proposals, but none has offered a bid that matches CFR's, so its discussions continue only with the Chile company. Beyond that, Adcock offered no further details about the talks.
